{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:28:35Z","timestamp":1765546115948},"reference-count":50,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.3892\/etm.2016.3657","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T05:26:44Z","timestamp":1473053204000},"page":"2489-2496","source":"Crossref","is-referenced-by-count":13,"title":["A meta-analysis of the effects of \u03b2-adrenergic blockers in chronic heart failure"],"prefix":"10.3892","volume":"12","author":[{"given":"Xiaojian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Wei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"key":"key20180108132630_b1-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.98.12.1184","article-title":"Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials","volume":"98","author":"Lechat","year":"1998","journal-title":"Circulation"},{"key":"key20180108132630_b2-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","article-title":"The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure","volume":"20","author":"Packer","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"key20180108132630_b3-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/oxfordjournals.eurheartj.a015297","article-title":"Effects of beta-blocker therapy on mortality in patients with heart failure: A systematic overview of randomized controlled trials","volume":"18","author":"Doughty","year":"1997","journal-title":"Eur Heart J"},{"key":"key20180108132630_b4-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0735-1097(97)00104-6","article-title":"Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials","volume":"30","author":"Heidenreich","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"key20180108132630_b5-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2261-13-52","article-title":"\u03b2-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials","volume":"13","author":"Al-Gobari","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"key20180108132630_b6-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"key20180108132630_b7-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"key20180108132630_b8-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0002-9149(85)90396-0","article-title":"A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy","volume":"55","author":"Anderson","year":"1985","journal-title":"Am J Cardiol"},{"key":"key20180108132630_b9-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"key20180108132630_b10-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehp100","article-title":"Amiodarone for the prevention of sudden cardiac death: A meta-analysis of randomized controlled trials","volume":"30","author":"Piccini","year":"2009","journal-title":"Eur Heart J"},{"key":"key20180108132630_b11-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJM200105313442202","article-title":"Beta-Blocker Evaluation of Survival Trial Investigators: A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure","volume":"344","year":"2001","journal-title":"N Engl J Med"},{"key":"key20180108132630_b12-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(97)80008-6","article-title":"No authors listed: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia\/New Zealand Heart Failure Research Collaborative Group","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"key20180108132630_b13-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.CIR.73.3.503","article-title":"Effect of propranolol after acute myocardial infarction in patients with congestive heart failure","volume":"73","author":"Chadda","year":"1986","journal-title":"Circulation"},{"key":"key20180108132630_b14-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/01.CIR.89.4.1632","article-title":"Bucindolol Investigators: Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators","volume":"89","author":"Bristow","year":"1994","journal-title":"Circulation"},{"key":"key20180108132630_b15-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"key20180108132630_b16-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"key20180108132630_b17-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"No authors listed: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"key20180108132630_b18-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","article-title":"No authors listed: A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"key20180108132630_b19-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0002-9149(00)00796-7","article-title":"Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties","volume":"85","author":"Witchitz","year":"2000","journal-title":"The CELICARD Group. Am J Cardiol"},{"key":"key20180108132630_b20-etm-0-0-3657","first-page":"2800","article-title":"Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure","volume":"94","author":"Colucci","year":"1996","journal-title":"US Carvedilol Heart Failure Study Group. Circulation"},{"key":"key20180108132630_b21-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group: Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"key20180108132630_b22-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1067\/mhj.2002.121807","article-title":"Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure","volume":"144","author":"de Milliano","year":"2002","journal-title":"Am Heart J"},{"key":"key20180108132630_b23-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurjhf\/hfr161","article-title":"Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study","volume":"14","author":"Conraads","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"key20180108132630_b24-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/01.CIR.72.3.536","article-title":"Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: A double-blind, randomized, placebo-controlled trial","volume":"72","author":"Engelmeier","year":"1985","journal-title":"Circulation"},{"key":"key20180108132630_b25-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0735-1097(94)90641-6","article-title":"Beneficial effects of metoprolol in heart failure associated with coronary artery disease: A randomized trial","volume":"23","author":"Fisher","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"key20180108132630_b26-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.284.6310.155","article-title":"One year's treatment with propranolol after myocardial infarction: Preliminary report of Norwegian multicentre trial","volume":"284","author":"Hansteen","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key20180108132630_b27-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.92.6.1499","article-title":"Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure","volume":"92","author":"Krum","year":"1995","journal-title":"Circulation"},{"key":"key20180108132630_b28-etm-0-0-3657","first-page":"1441","article-title":"Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy","volume":"342","author":"Waagstein","year":"1993","journal-title":"Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet"},{"key":"key20180108132630_b29-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"No authors listed: Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"key20180108132630_b30-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/0735-1097(94)90174-0","article-title":"Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy","volume":"24","author":"Metra","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"key20180108132630_b31-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0735-1097(95)00012-S","article-title":"Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study","volume":"25","author":"Olsen","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"key20180108132630_b32-etm-0-0-3657","first-page":"1349","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"U.S. Carve-dilol Heart Failure Study Group. N Engl J Med"},{"key":"key20180108132630_b33-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0002-9149(90)90488-M","article-title":"Usefulness of bucindolol in congestive heart failure","volume":"66","author":"Pollock","year":"1990","journal-title":"Am J Cardiol"},{"key":"key20180108132630_b34-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.CIR.101.4.378","article-title":"No authors listed: Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: the randomized evaluation of strategies of left ventricular dysfunction pilot study","volume":"101","year":"2000","journal-title":"Circulation"},{"key":"key20180108132630_b35-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"key":"key20180108132630_b36-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1388-9842(00)00120-3","article-title":"Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril","volume":"2","author":"Sturm","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"key20180108132630_b37-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1071-9164(97)90026-9","article-title":"Nebivolol in the treatment of cardiac failure: A double-blind controlled clinical trial","volume":"3","author":"Uhlir","year":"1997","journal-title":"J Card Fail"},{"key":"key20180108132630_b38-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/0735-1097(93)90230-X","article-title":"Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy","volume":"21","author":"Wisenbaugh","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"key20180108132630_b39-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/01.CIR.84.6.2426","article-title":"Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy","volume":"84","author":"Woodley","year":"1991","journal-title":"Circulation"},{"key":"key20180108132630_b40-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.160.5.621","article-title":"Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials","volume":"160","author":"Bonet","year":"2000","journal-title":"Arch Intern Med"},{"key":"key20180108132630_b41-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pupt.2007.07.002","article-title":"The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study","volume":"21","author":"Hanania","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"key20180108132630_b42-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.cjca.2014.02.012","article-title":"\u03b2-Blockers in Hypertension: studies and meta-analyses over the years","volume":"30","author":"Larochelle","year":"2014","journal-title":"Can J Cardiol"},{"key":"key20180108132630_b43-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4236\/pp.2015.65029","article-title":"Beta Blockers Use in Cardiac Failure: Does the Current Prescribing Practice at a Large Urban Hospital in Zimbabwe Exhibit Evidence Based Care and Offer Optimal Therapy for Cardiac Failure Patients?","volume":"6","author":"Matowa","year":"2015","journal-title":"Pharmacology & Pharmacy"},{"key":"key20180108132630_b44-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with \u03b2-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"key20180108132630_b45-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10741-014-9453-8","article-title":"Beta-blockers in heart failure with preserved ejection fraction: A meta-analysis","volume":"20","author":"Bavishi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"key20180108132630_b46-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2147\/OTT.S78836","article-title":"Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients","volume":"8","author":"Lu","year":"2015","journal-title":"Onco Targets Ther"},{"key":"key20180108132630_b47-etm-0-0-3657","first-page":"III236","article-title":"Prevention of supraventricular arrhythmias after coronary artery bypass surgery","volume":"84","author":"Andrews","year":"1991","journal-title":"A meta-analysis of randomized control trials. Circulation"},{"key":"key20180108132630_b48-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"f55","DOI":"10.1136\/bmj.f55","article-title":"Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis","volume":"346","author":"Chatterjee","year":"2013","journal-title":"BMJ"},{"key":"key20180108132630_b49-etm-0-0-3657","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.4238\/2015.June.1.9","article-title":"Association between \u03b21 adrenergic receptor gene Arg389Gly polymorphism and risk of heart failure: a meta-analysis","volume":"14","author":"Ma","year":"2015","journal-title":"Genet Mol Res"},{"key":"key20180108132630_b50-etm-0-0-3657","first-page":"CD006342","article-title":"Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery","volume":"1","author":"Mostafaie","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3657\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T18:25:58Z","timestamp":1515435958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,5]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,9,5]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.3892\/etm.2016.3657"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3657","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,5]]}}}